Kathy Bates' Ozempic Story: 100 Pounds, Seven Years, and the Final 15-20
Kathy Bates says most of her 100-pound weight loss came from years of lifestyle change, with Ozempic helping during the final stretch.
Your source for the latest biohacking research news
Kathy Bates says most of her 100-pound weight loss came from years of lifestyle change, with Ozempic helping during the final stretch.
Elon Musk helped push GLP-1 weight-loss drugs into the public conversation after crediting fasting, Wegovy, and later Mounjaro for a leaner look.
Sharon Osbourne has said Ozempic helped her lose about 42 pounds, then warned that the result went too far after she became thinner than she wanted.
Meghan Trainor confirmed using Mounjaro after her second pregnancy, later framing her roughly 60-pound transformation as the result of medical support, a dietitian, a trainer, and lifestyle changes.
Fat Joe says low-carb eating, portion control, and a prescribed diabetes medication helped him maintain one of hip-hop's most visible long-term weight-loss transformations.
Serena Williams went public about using Zepbound (tirzepatide) after struggling with post-pregnancy weight changes. What her story teaches about GLP-1s, postpartum biology, and why discipline alone isn't always the answer.
Shaquille O'Neal went public about using Zepbound (tirzepatide) for obstructive sleep apnea. What his story teaches about GLP-1s, sleep, and longevity.
GLP-1 receptor agonists shifted how clinicians and the public think about obesity in just a few years. Here's what they actually are, what the research shows, and what's still being studied.
A plain-language home for the research that matters in recovery, sleep, longevity, peptides, and performance — written for readers who want citations, not vibes.
New research suggests that recovering from chronic sleep loss takes far longer than a single weekend — and that some cognitive deficits persist even after sleep is restored.
A new systematic review pulls every published BPC-157 tendon study to date. The animal data are striking; the human data remain almost nonexistent.
Zone 2 training is having a moment. A new controlled trial compares it head-to-head with HIIT and finds the two protocols produce different mitochondrial adaptations — both useful, neither magic.
Creatine has 30 years of muscle-strength data behind it. A new meta-analysis of 26 trials finally answers whether it does anything for the brain — and the answer is a qualified yes.